CDMO News
Seven Recipharm OSD Facilities Sold to Blue Wolf Capital for New CDMO
In a significant move that signals the ongoing reshaping of the Contract Development and Manufacturing Organisation (CDMO) industry, Recipharm has sold off seven of its manufacturing and development facilities in Europe. The buyer is the U.S. private equity firm, Blue Wolf Capital.
3 April 2024